ABSTRACr From 1956 to 1980 85 patients were admitted to the Brompton Hospital, London, with pulmonary aspergilloma. The mean follow-up period was 8-7 years and 85% of patients were followed for five years or until death if this was earlier. There were 41 deaths, 27 from respiratory causes: 11 from pneumonia, six from chronic respiratory failure, seven after surgery for aspergilloma, and three from haemoptysis. Medical treatment alone was given to 36 patients, of whom three died of haemoptysis. Systemic antifungal treatment was given to 18 patients without benefit. Intracavitary antifungals were helpful in three out of 10 patients. Surgical resection was performed in 41 patients, of whom three (7%) died after operation and a further six (15%) developed major complications. Cavernostomy was performed in nine patients considered unfit for resection; four died after operation. Haemoptysis was absent or minor in 40 patients, of whom 19 were treated medically and 18 by resection, with similar five-year survival rates of 65% and 75%. Frank or major haemoptysis occurred in 45 patients, of whom 17 were treated medically and 23 by resection, with five-year survivals of 41% and 84% (p < 0.02). The better survival of the surgical group in this retrospective survey may have been due to the selection of patients with better lung function and more localised pulmonary disease. Our observations suggest that surgical resection for aspergilloma should be restricted to patients with severe haemoptysis and adequate pulmonary function. In patients unfit for resection cavernostomy is hazardous.
Many patients with pulmonary aspergillomas suffer from haemoptysis.1-7 Episodes of haemoptysis may be treated medically or prevented by surgical resection but the choice of method is contentious.5`12
We undertook a retrospective survey of 85 patients with pulmonary aspergilloma and analysed the results of medical and surgical treatment with special reference to the severity of haemoptysis. This is the largest published series of which we are aware.
Methods
We obtained case records of 85 patients admitted to the Brompton Hospital, London, with pulmonary aspergilloma from 1956 to 1980 by referring to the hospital's diagnostic index. The criteria for inclusion in the study were the presence of a rounded opacity in a pulmonary cavity on a plain chest radiograph or tomogram" and of serum precipitins to aspergillus extracts.14 The maximum diameter of the aspergilloma was measured from standard posteroanterior chest radiographs, without correction for magnification effects.
Only patients admitted to hospital were included. During the 25 years management varied between individual physicians and surgeons. Follow-up lung disease. The primary lesion affected both lungs in 54 patients (63%). Skinprick testing with Aspergillus fumigatus extract gave an immediate positive response in 39 of the 56 patients tested (70%). Asthma occurred in 22 patients, of whom 10 had allergic bronchopulmonary aspergillosis. Four patients had Marfan's syndrome and two patients Fallot's tetralogy, one with tuberculosis and one with no previous lung disease. Mycobacterium xenopii infection occurred in two patients, one with polyarteritis and one with allergic aspergillosis. Seven patients had had a partial gastrectomy for peptic ulcer.
Aspergillomas occurred with equal frequency in each lung. All were situated in the upper lobes except for two in the right middle lobe and three in the lower lobes. Three occurred at the apex of the lower lobe after upper lobectomy. The maximum diameter varied from 2 to 10 cm (mean 4.5 cm).
Nineteen patients (22%) had more than one aspergilloma; in 12 cases these were bilateral. The interval between the first and second aspergilloma, as judged by review of chest radiographs, was one year or less for 11 patients and two to three years for five patients. In one of these cases and in all three with a longer interval (four to 10 years) the first aspergilloma had been resected before the second appeared.
Spontaneous resolution of the aspergilloma was noted in two patients after five and 17 years respectively. Both developed a second aspergilloma later, one in the same cavity and the other in the contralateral lung.
Seventy-two patients (85%) were followed for a minimum of five years unless death supervened, and 25 patients have been followed for 10 years or more. Forty-one patients are known to have died, at a mean of 5*5 years from diagnosis. Thirty-three are known to be alive after a mean period of 9-9 years. Eleven were lost to follow-up, five immediately after discharge and six after a mean period of Seven patients died after surgery, three after resection and four after cavernostomy. The mortality for pulmonary resection was three out of 41 patients (7%).
Seventeen patients died of respiratory disease not directly related to the aspergilloma-six from chronic respiratory insufficiency, six (all with compromised pulmonary function) from pneumonia, and five from chronic pulmonary suppuration. Two of the latter group died from cachexia and respiratory failure, two after operations to remove the cavitated lung, and one from massive bleeding.
HAEMOPTYSIS
Sixty-six patients (78%) had haemoptysis at some stage. Patients were grouped according to the worst haemoptysis they had experienced: group 1-no haemoptysis (14 patients); group 2-minor haemoptysis in which the sputum was streaked or stained with blood (26 patients); group 3-frank haemoptysis with expectoration of pure blood (24 patients); group 4-major haemoptysis exceeding 150 ml in 24 hours' (21 patients). 
574
The severity of haemoptysis was not related to the size or number of aspergillomas or to the nature of the underlying lung diseases, erythrocyte sedimentation rate, blood eosinophil count, or skinprick test results.
Frank haemoptysis preceded major haemoptysis by six months to three years in 12 patients in group 4. The other nine patients had no haemoptysis before their first major bleed. The first major haemoptysis led to the diagnosis of aspergilloma in eight patients, occurred within a year of diagnosis in four, and a mean of three years from the diagnosis in nine patients.
All 21 patients with major haemoptysis survived their first bleed with conservative treatment. Eight underwent surgery within a few weeks. Recurrent major haemoptysis occurred in eight of the remaining 13 patients after intervals ranging from two weeks to seven years (median six months).
Eight patients in group 4 were never treated surgically. Three died from haemoptysis two weeks, six weeks, and three years after their first major haemoptysis. Three died from unrelated diseases one to six years later and two survived 10 years.
Thirteen patients in group 4 were treated surgically (12 by resection and one by cavernostomy), with three postoperative deaths (including the patient who had a cavernostomy). One patient died six months later from asthma. The remaining nine patients were alive at the time of follow-up.
Thus three patients died directly from haemoptysis and three from surgery to prevent haemoptysis, a total of six patients-7% of the whole series. single attempt at bronchoscopic instillation failed. Three aspergillomas in two patients disappeared over a few months, and one in a third patient shrank considerably, all after treatment with brilliant green. Adverse reactions, often following the earlier instillations, occurred in six patients; they consisted of cough, fever, malaise, chest pain, and clinical or radiological signs of consolidation around the mycetoma. None of these was life threatening. A seventh patient required ventilation for an asthmatic attack after generalised aspiration of brilliant green and radiographic contrast material. Immediate skin reactions to aspergillus extracts were positive in four of these seven patients. Eight of the 10 patients had no haemoptysis after the instillations. Frank haemoptysis occurred some hours after several instillations into each of the bilateral aspergillomas in one patient while another patient, with four previous major haemoptyses, had fatal haemoptysis on the day after her third intracavitary instillation. surgery. One death was due to sudden, uncontrolled bleeding; a second to bronchopleural fistula and secondary haemorrhage; and the third to respiratory failure after completion of a right pneumonectomy in a patient who had already undergone bilateral lowerlobe lobectomy for bronchiectasis. Six patients (15%) developed major complications. Three required further surgery within 24 hours to control bleeding. Bronchopleural fistula developed in three patients; two of them, after upper-lobe lobectomy in both cases, were successfully treated by intercostal muscle-flap closure of the fistula and a thoracoplasty while the third required long-term tube drainage after a pneumonectomy.
Three patients died within five years of resection. One patient died from asthma six months after pneumonectomy, one from pneumonia two years after lobectomy, and one from massive haemorrhage from a lung abscess. There was no evidence of aspergilloma at necropsy.
Three patients developed radiological evidence of contralateral aspergilloma one to four years after pulmonary resection. Tests for serum aspergillus precipitins gave negative results in one and strongly positive results in two. Eleven patients without evidence of recurrent aspergilloma one to seven years after resection had tests for precipitins, and results were negative in eight, weakly positive in two, and strongly positive in one. 10 Cavernostomy Cavernostomy was performed in nine patients for whom pulmonary resection was considered too hazardous because of their widespread lung disease and poor pulmonary function (mean FEVI 1.34 1, mean FVC 2-06 1). Two patients came from group 1, two from group 2, four from group 3 and one from group 4. Evacuation of the aspergillomal5 was followed by instillation of antifungal agents (brilliant green in one and natamycin in the others) once or twice daily for three to four weeks. 16 Four patients died after operation (44%). One died from haemorrhage and one from haemoptysis after developing Serratia marcescens pneumonia. Two other patients died from pneumonia. Both patients became hypotensive and developed pulmonary shadowing on the second postoperative day, shortly after the second natamycin irrigation. The cause of the pneumonia was not apparent at necropsy. Gram-negative septicaemia or an adverse reaction to natamycin are possibilities.
One patient died six years after the cavernostomy during resection of a chronically suppurating lower lobe (with no evidence of aspergilloma). The remaining four patients are alive from three to 17 years after cavernostomy. Two survivors have no radiological evidence of aspergilloma and tests for aspergillus precipitins have given negative results. A third patient, who had bilaterial aspergillomas, has an empty cavernostomy cavity. In the fourth patient the aspergilloma recurred within two months. We have confirmed that the upper lobes are the predominant site of aspergillomas and that multiple aspergillomas are common, occurring in 22% of our patients. The size was very variable and bore no relation to the severity of haemoptysis.
The commonest predisposing pulmonary lesions were tuberculosis, other causes of upper-lobe fibrosis, and sarcoidosis. No predisposing cause was found in five patients (6%). The association between Marfan's syndrome and aspergilloma has been reported recently. 20 An unexpectedly large number of patients (8%) had previously had a partial gastrectomy.
Spontaneous resolution of the aspergilloma occurred in only two (5%) of our medically treated patients. In other, smaller series1 2 5 the rate of spontaneous resolution varied from zero to 37%. In the larger series reported by the research committee of the British Thoracic and Tuberculosis Association (BTTA) the rate was 5% over three years.21 22 Recurrent aspergillomas occurred in three of the 41 (7%) patients who underwent resection. The 
